Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hein Putter

Showing results (481-490 of 512) with videos related to

Pageof 52
Sort By:
Cancers|October 23, 2021
PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune SystemAnouk Corbeau, Remi A Nout, Jan Willem M Mens, et al.
The Lancet. Oncology|April 14, 2018
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trialAnnemieke Cats, Edwin P M Jansen, Nicole C T van Grieken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2020
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant TherapyAlicia León-Castillo, Stephanie M de Boer, Melanie E Powell, et al.
Annals of Surgery|July 12, 2018
Effect of Hospital Volume With Respect to Performing Gastric Cancer Resection on Recurrence and Survival: Results From the CRITICS TrialYvette H M Claassen, Romy M van Amelsfoort, Henk H Hartgrink, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation TherapyBastiaan G Wortman, Cathalijne C B Post, Melanie E Powell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2022
Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB TrialSonja B Vliek, Iris Noordhoek, Elma Meershoek-Klein Kranenbarg, et al.
Annals of Surgical Oncology|March 2, 2011
Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancerJ Sven D Mieog, Susan L Troyan, Merlijn Hutteman, et al.
The Lancet. Oncology|December 10, 2020
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trialRenu R Bahadoer, Esmée A Dijkstra, Boudewijn van Etten, et al.
Journal of the National Cancer Institute|March 11, 2021
Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial CancerCathalijne C B Post, Ellen Stelloo, Vincent T H B M Smit, et al.
Gynecologic Oncology|October 12, 2020
Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer - a randomized controlled trialMarion M Deken, Helena C van Doorn, Danielle Verver, et al.
Pageof 52

Showing results (481-490 of 512) with videos related to

Sort By:
Pageof 52
Cancers|October 23, 2021
PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune SystemAnouk Corbeau, Remi A Nout, Jan Willem M Mens, et al.
The Lancet. Oncology|April 14, 2018
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trialAnnemieke Cats, Edwin P M Jansen, Nicole C T van Grieken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2020
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant TherapyAlicia León-Castillo, Stephanie M de Boer, Melanie E Powell, et al.
Annals of Surgery|July 12, 2018
Effect of Hospital Volume With Respect to Performing Gastric Cancer Resection on Recurrence and Survival: Results From the CRITICS TrialYvette H M Claassen, Romy M van Amelsfoort, Henk H Hartgrink, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation TherapyBastiaan G Wortman, Cathalijne C B Post, Melanie E Powell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2022
Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB TrialSonja B Vliek, Iris Noordhoek, Elma Meershoek-Klein Kranenbarg, et al.
Annals of Surgical Oncology|March 2, 2011
Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancerJ Sven D Mieog, Susan L Troyan, Merlijn Hutteman, et al.
The Lancet. Oncology|December 10, 2020
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trialRenu R Bahadoer, Esmée A Dijkstra, Boudewijn van Etten, et al.
Journal of the National Cancer Institute|March 11, 2021
Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial CancerCathalijne C B Post, Ellen Stelloo, Vincent T H B M Smit, et al.
Gynecologic Oncology|October 12, 2020
Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer - a randomized controlled trialMarion M Deken, Helena C van Doorn, Danielle Verver, et al.
Pageof 52